Botulinum toxin A injections in the treatment of axillary hyperhidrosis: a prospective study reviewing quality of life and patient satisfaction in a UK tertiary dermatology centre

Clin Exp Dermatol. 2022 Jul;47(7):1358-1359. doi: 10.1111/ced.15164. Epub 2022 Apr 4.

Authors

Leila Asfour^{1

2}, Anthony Moussa², Zoe Littlewood¹, Jennifer Sharif¹, John Newsham¹, Nuala O'Donoghue¹, Stephanie Ogden¹, Emma McMullen¹, Hamish Hunter¹

Affiliations

¹ Department of Dermatology, Salford Royal Foundation Trust, Manchester, UK.
² Sinclair Dermatology, Melbourne, VIC, Australia.

PMID: 35262223
DOI: 10.1111/ced.15164

No abstract available

Publication types

Letter

MeSH terms

Axilla
Botulinum Toxins, Type A* / therapeutic use
Dermatology*
Humans
Hyperhidrosis* / drug therapy
Injections, Intradermal
Neuromuscular Agents* / therapeutic use
Patient Satisfaction
Prospective Studies
Quality of Life
Treatment Outcome
United Kingdom

Substances

Neuromuscular Agents
Botulinum Toxins, Type A